List name | Country | Independent of diagnosis (7/9) | Dosage (6/9) | Duration of therapy (4/9) | Disease-drug interactions (6/9) | Drug-drug interactions (7/9) | Duplication (3/9) | Alternative therapies (4/9) | Special consideration of use (4/9) |
---|---|---|---|---|---|---|---|---|---|
McLeod criteria | Canada | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Rancourt criteria | Canada | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Lindblad criteria | USA | ✓ | |||||||
Laroche criteria | France | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
Winit-Watjana criteria | Thailand | ✓ | ✓ | ✓ | |||||
NORGEP | Norway | ✓ | ✓ | ✓ | |||||
PRISCUS | Germany | ✓ | ✓ | ✓ | ✓ | ||||
STOPP version 2 | Ireland | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Beers criteria | USA | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |